Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $173,880 - $239,719
400 Added 2.27%
18,000 $9.67 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $6.98 Million - $9.33 Million
-19,900 Reduced 53.07%
17,600 $8.25 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $11.6 Million - $13.7 Million
37,500 New
37,500 $12.9 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $5.19 Million - $5.91 Million
17,500 New
17,500 $5.66 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $21.1 Million - $26.2 Million
-90,000 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $20.2 Million - $25.1 Million
90,000 New
90,000 $24.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.